Synthesis and structural characterization of new macrocyclicplasmin inhibitors
Guojie, W.(2023) ChemMedChem 
Experimental Data Snapshot
Starting Model: experimental
View more details
(2023) ChemMedChem 
Macromolecule Content 
Entity ID: 1 | |||||
|---|---|---|---|---|---|
| Molecule | Chains | Sequence Length | Organism | Details | Image |
| Plasminogen | 250 | Homo sapiens | Mutation(s): 1  Gene Names: PLG EC: 3.4.21.7 | ![]() | |
UniProt & NIH Common Fund Data Resources | |||||
PHAROS:  P00747 GTEx:  ENSG00000122194  | |||||
Entity Groups | |||||
| Sequence Clusters | 30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity | ||||
| UniProt Group | P00747 | ||||
Sequence AnnotationsExpand | |||||
Reference Sequence | |||||
| Ligands 3 Unique | |||||
|---|---|---|---|---|---|
| ID | Chains | Name / Formula / InChI Key | 2D Diagram | 3D Interactions | |
| EUA (Subject of Investigation/LOI) Download:Ideal Coordinates CCD File | C [auth A], G [auth B] | (6S,9R,19S,22R)-N-{[4-(aminomethyl)phenyl]methyl}-22-[(benzenesulfonyl)amino]-3,12,21-trioxo-2,6,9,13,20-pentaazatetracyclo[22.2.2.2~6,9~.2~14,17~]dotriaconta-1(26),14,16,24,27,29-hexaene-19-carboxamide C42 H50 N8 O6 S AFXLLOQEGPNGRX-QPPIDDCLSA-N | |||
| SO4 Download:Ideal Coordinates CCD File | D [auth A] E [auth A] F [auth A] H [auth B] I [auth B] | SULFATE ION O4 S QAOWNCQODCNURD-UHFFFAOYSA-L | |||
| GOL Download:Ideal Coordinates CCD File | N [auth B] | GLYCEROL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N | |||
| Length ( Å ) | Angle ( ˚ ) |
|---|---|
| a = 48.678 | α = 90 |
| b = 50.193 | β = 93.31 |
| c = 92.024 | γ = 90 |
| Software Name | Purpose |
|---|---|
| PHENIX | refinement |
| SCALA | data scaling |
| PDB_EXTRACT | data extraction |
| XDS | data reduction |
| PHASER | phasing |
| Funding Organization | Location | Grant Number |
|---|---|---|
| National Health and Medical Research Council (NHMRC, Australia) | Australia | APP1127593 |